IPHA
Innate Pharma ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.50
+0.00 +0.00%
🌙 3월 13일 4:20 PM ET (한국 3/14 05:20)
$1.51
+0.01 ▲ +0.67%
| Index | - | P/E | - | EPS (ttm) | -0.6 | Insider Own | - | Shs Outstand | 0.09B | Perf Week | -6.25% |
| Market Cap | 0.14B | Forward P/E | - | EPS next Y | 18.18% | Insider Trans | - | Shs Float | - | Perf Month | -11.76% |
| Enterprise Value | 0.10B | PEG | - | EPS next Q | - | Inst Own | 0.29% | Short Float | - | Perf Quarter | -18.92% |
| Income | -0.05B | P/S | 21.6 | EPS this Y | 2.78% | Inst Trans | 0.31% | Short Ratio | 4.43 | Perf Half Y | -26.47% |
| Sales | 0.01B | P/B | 22.89 | EPS next 5Y | -7.86% | ROA | -36.88% | Short Interest | 0.10M | Perf YTD | -14.29% |
| Book/sh | 0.07 | P/C | 2 | EPS past 3/5Y | 5.6% -13.71% | ROE | -271.32% | 52W High | -42.97% ($2.63) | Perf Year | -24.81% |
| Cash/sh | 0.75 | P/FCF | - | Sales past 3/5Y | -1.57% -29.28% | ROIC | -183.5% | 52W Low | 7.14% ($1.40) | Perf 3Y | -49.32% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -31.24% | Gross Margin | - | Volatility(W/M) | 7.06% 5.31% | Perf 5Y | -67.18% |
| Dividend TTM | - | EV/Sales | 15.65 | Sales Y/Y TTM | -75.77% | Oper. Margin | -957.33% | ATR (14) | 0.1 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.21 | EPS Q/Q | 19% | Profit Margin | -768.78% | RSI (14) | 34.85 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.21 | Sales Q/Q | -79.64% | SMA20 | -8.8% ($1.64) | Beta | 0.04 | Target Price | $8 |
| Payout | - | Debt/Eq | 5.25 | Earnings | 3000000 | SMA50 | -12.74% ($1.72) | Rel Volume | 1.73 | Prev Close | $1.5 |
| Employees | 181 | LT Debt/Eq | 3.52 | EPS/Sales Surpr. | 9.8% -59.09% | SMA200 | -21.58% ($1.91) | Avg Volume(3M) | 0.02M | Price | $1.5 |
| IPO | 2019/10/17 | Option/Short | No/Yes | Trades | 431 | Volume | 38,792 | Change | - |
뉴스 로딩 중...